Natco Pharma receives USFDA approval for Vidaza
Natco Pharma Ltd has got the final USFDA approval for the generic version of Vidaza (Azacitidine for injection, 100 mg per vial), single-dose vial. Natco […]
Uncategorized
Unichem Laboratories receives USFDA approval for Piroxicam
Unichem Laboratories has received final USFDA approval for Piroxicam capsules, used in the treatment of osteoarthritis and rheumatoid arthritis, in the US market. The approved […]
Lupin receives USFDA approval to market Tobi in US
Lupin has received final USFDA approval to market a generic version of Novartis’ inhalation product Tobi, which is used to treat cystic fibrosis, in the […]
Alembic Pharma receives USFDA approval for fenofibric acid delayed release capsules
Alembic Pharmaceuticals has received final USFDA approval for Fenofibric acid delayed-release capsules used for lowering high cholesterol and increasing good cholesterol. The approved product is […]
Alembic receives USFDA approval for olmesartan and hydrochlorothiazide
Alembic Pharmaceuticals has received final USFDA approval for two anti-hypertension tablets – olmesartan medoxomil tablets, 5 mg, 20 mg, and 40 mg and olmesartan medoxomil […]
Wockhardt receives USFDA approval for generic version of Wyeth Zosyn
Wockhardt has received USFDA approval to market generic version of Wyeth’s Zosyn, used for treating bacterial infections, in the American market. Wockhardt Bio AG had […]
Glenmark Pharma receives USFDA approval for clobetasol propionate
Glenmark Pharmaceuticals has received USFDA approval for Clobetasol Propionate Ointment used for treatment of various skin conditions. The approved product is a generic version of […]
Lupin receives USFDA approval for sodium sulfate/potassium sulfate and magnesium sulfate
Lupin Ltd has received final USFDA approval to market sodium sulfate, potassium sulfate, magnesium sulfate oral solution used in colonoscopy. The company will market sodium […]
Mylan and Biocon receives USFDA approval for BLA for MYL-1401H
Mylan Pharma has received USFDA approval for its biologics licence application (BLA) for MYL-1401H, a proposed biosimilar Pegfilgrastim. The proposed biosimilar Pegfilgrastim is one of […]
Zydus Cadila receives USFDA approval for fluconazole
Zydus Cadila has received final USFDA approval to market fluconazole tablets used for the treatment of fungal infections in USA market. The company also received […]